Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Liam Price just cracked a 60-year-old problem that world-class mathematicians have tried and failed to solve. He’s 23 years old and has no advanced mathematics training. What he does have is a ChatGPT ...

Abstract: The Subset Sum problem is a classical NP-complete problem with applications in resource allocation, cryptography, and combinatorial optimization. Conventional backtracking methods search the ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

What Caitlin Clark’s Treatment Tells Us About the WNBA America Is Still a ‘Land of Wonders’ Zohran Mamdani’s Bogus Explanation for Opposing Israel The Man Who Saved the Declaration of Independence ...

In Whose Name? tries to be honest—or, as honest as an offering of less than two hours out of 3,000 can be. Where most documentaries would spend a significant amount of time recapping the incredible ...

One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...

Several stocks on the market offer investors the opportunity to capitalize on the rapidly growing field of artificial intelligence (AI). The list includes some of the "Magnificent Seven" stocks, as ...